CONOZID

  • Therapeutic Category
    • CARDIOVASCULAR DRUGS
    • BETA-ADRENOCEPTOR BLOCKING AGENTS
  • Pharmaceutical Form : Tablets
  • Composition : Bisoprolol 5 mg + Hydrochlorothiazide 6.25 mg /Tab
  • Active Substance : Bisoprolol+Hydrochlorothiazide

INDICATIONS :
CONOZID is indicated in the management of hypertension .
Dosage and administration :
Bisoprolol is an effective treatment of hypertension in once daily doses of 2.5 to 40 mg, while Hydrochlorothiazide is effective in doses of 12.5 to 50 mg. in clinical trails of Bisoprolol / Hydrochlorothiazide combination therapy using Bisoprolol doses of 2.5 to 20 mg and Hydrochlorothiazide doses of 6.25 to 25 mg the antihypertensive effects increased with increasing doses of either component.